|
1
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ:
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. New Eng J
Med. 348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Sanjose S, Quint WG, Alemany L, Geraets
DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin
HR, et al: Human papillomavirus genotype attribution in invasive
cervical cancer: A retrospective cross-sectional worldwide study.
Lancet Onco. 11:1048–1056. 2010. View Article : Google Scholar
|
|
4
|
Guan P, Howell-Jones R, Li N, Bruni L, de
Sanjosé S, Franceschi S and Clifford GM: Human papillomavirus (HPV)
types in 115,789 HPV-positive women: A meta-analysis from cervical
infection to cancer. Int J Cancer. 131:2349–2359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bosch FX, Manos MM, Muñoz N, Sherman M,
Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV:
Prevalence of human papillomavirus in cervical cancer: A worldwide
perspective. International biological study on cervical cancer
(IBSCC) Study Group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Palefsky JM, Minkoff H, Kalish LA, Levine
A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P and Burk R:
Cervicovaginal human papillomavirus infection in human
immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative
women. J Natl Cancer Inst. 91:226–236. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pett M and Coleman N: Integration of
high-risk human papillomavirus: A key event in cervical
carcinogenesis? J Pathol. 212:356–367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Doeberitz MV and Vinokurova S: Host
factors in HPV-related carcinogenesis: Cellular mechanisms
controlling HPV infections. Arch Med Res. 40:435–442. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen HC, Schiffman M, Lin CY, Pan MH, You
SL, Chuang LC, Hsieh CY, Liaw KL, Hsing AW and Chen CJ: CBCSP-HPV
Study Group: Persistence of type-specific human papillomavirus
infection and increased long-term risk of cervical cancer. J Natl
Cancer Inst. 103:1387–1396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pardo C and Cendales R: Incidencia,
Mortalidad y Prevalencia de Cáncer en Colombia, 2007–2011. First
edtion. 1. Instituto Nacional de Cancerología; Bogotá, DC: pp.
1482015, (In Spanish).
|
|
11
|
Molano M, Posso H, Weiderpass E, van den
Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A and Munoz
N: HPV Study Group HPV Study: Prevalence and determinants of HPV
infection among Colombian women with normal cytology. Br J Cancer.
87:324–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muñoz N, Méndez F, Posso H, Molano M, van
den Brule AJ, Ronderos M, Meijer C and Muñoz A: Instituto Nacional
de Cancerologia HPV Study Group: Incidence, duration and
determinants of cervical human papillomavirus infection in a cohort
of Colombian women with normal cytological results. J Infect Dis.
190:2077–2087. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mendez F, Munoz N, Posso H, Molano M,
Moreno V, van den Brule AJ, Ronderos M, Meijer C and Munoz A:
Instituto Nacional de Cancerologia Human Papillomavirus Study
Group: Cervical coinfection with human papillomavirus (HPV) types
and possible implications for the prevention of cervical cancer by
HPV vaccines. J Infect Dis. 192:1158–1165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Serrano B, Alemany L, Tous S, Bruni L,
Clifford GM, Weiss T, Bosch FX and de Sanjosé S: Potential impact
of a nine-valent vaccine in human papillomavirus related cervical
disease. Infect Agent Cancer. 7:382012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xin CY, Matsumoto K, Yoshikawa H, Yasugi
T, Onda T, Nakagawa S, Yamada M, Nozawa S, Sekiya S, Hirai Y, et
al: Analysis of E6 variants of human papillomavirus type 33, 52 and
58 in Japanese women with cervical intraepithelial
neoplasia/cervical cancer in relation to their oncogenic potential.
Cancer Lett. 170:19–24. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan PK, Lam CW, Cheung TH, Li WW, Lo KW,
Chan MY, Cheung JL and Cheng AF: Association of human
papillomavirus type 58 variant with the risk of cervical cancer. J
Natl Cancer Inst. 94:1249–1253. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calleja-Macias IE, Villa LL, Prado JC,
Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE,
Dunn ST, et al: Worldwide genomic diversity of the high-risk human
papillomavirus types 31, 35, 52 and 58, four close relatives of
human papillomavirus type 16. J Virol. 79:13630–13640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Roda Husman AM, Walboomers JM, van den
Brule AJ, Meijer CJ and Snijders PJ: The use general primers GP5
and GP6 elongated at their 3′ ends with adjacent highly conserved
sequences improves human papillomavirus detection by PCR. J Gen
Virol. 76:1057–1062. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benson DA, Karsch-Mizrachi I, Lipman DJ,
Ostell J and Wheeler DL: GenBank. Nucleic Acids Res. 33:D34–D38.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu EQ, Zha X, Yu XH, Zhang GN, Wu YG, Fan
Y, Ren Y, Kong LQ and Kong W: Profile of physical status and gene
variation of human papillomavirus 58 genome in cervical cancer. J
Gen Virol. 90:1229–1237. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang YJ, Chen HC, Lee BH, You SL, Lin CY,
Pan MH, Chou YC, Hsieh CY, Chen YM, Cheng YJ, et al: Unique
variants of human papillomavirus genotypes 52 and 58 and risk of
cervical neoplasia. Int J Cancer. 129:965–973. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan PK: Human papillomavirus type 58: The
unique role in cervical cancers in East Asia. Cell Biosci.
2:172012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Veras VS, Cerqueira DM and Martins CR: L1
sequence of a new human papillomavirus type-58 variant associated
with cervical intraepithelial neoplasia. Braz J Med Biol Res.
38:1–4. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raiol T, Wyant PS, de Amorim RM, Cerqueira
DM, Milanezi Nv, Brígido Mde M, Sichero L and Martins CR: Genetic
variability and phylogeny of the high-risk HPV-31, −33, −35, −52
and −58 in central Brazil. J Med Virol. 81:65–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Canche JC, López IR, Suárez NG, Acosta GC,
Conde-Ferráez L, Cetina TC and Losa MR: High prevalence and low E6
genetic variability of human papillomavirus 58 in women with
cervical cancer and precursor lesions in Southeast Mexico. Mem Inst
Oswaldo Cruz. 105:144–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Godínez JM, Heideman DA, Gheit T, Alemany
L, Snijders PJ, Tommasino M, Meijer CJ, de Sanjosé S, Bosch FX and
Bravo IG: Differential presence of Papillomavirus variants in
cervical cancer: An analysis for HPV33, HPV45 and HPV58. Infect
Genet Evol. 13:96–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buitrago O, Morales N, Martín C, Huertas
A, Moreno P, Martínez T and Molano M: Presencia y persistencia de
variantes moleculares del ORF E6 y ORF E7 del VPH58 en mujeres con
citología normal que pertenecen a la cohorte de Bogotá, Colombia.
Rev Colomb Cancerol. 16:40–48. 2012.(In Spanish).
|
|
28
|
Mejía L, Muñoz D, Trueba G, Tinoco L and
Zapata S: Prevalence of human papillomavirus types in cervical
cancerous and precancerous lesions of Ecuadorian women. J Med
Virol. 88:144–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gurgel AP, Chagas BS, do Amaral CM,
Nascimento KC, Leal LR, Silva Neto Jda C, Muniz Cartaxo MT and de
Freitas AC: Prevalence of human papillomavirus variants and genetic
diversity in the L1 gene and long control region of HPV16, HPV31
and HPV58 found in North-East Brazil. Biomed Res Int.
2015:1308282015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chan PK, Luk AC, Park JS, Smith-McCune KK,
Palefsky JM, Konno R, Giovannelli L, Coutlée F, Hibbitts S, Chu TY,
et al: Identification of human papillomavirus type 58 lineages and
the distribution worldwide. Infect Dis. 203:1565–1573. 2011.
View Article : Google Scholar
|
|
31
|
Chan PK, Zhang C, Park JS, Smith-McCune
KK, Palefsky JM, Giovannelli L, Coutlée F, Hibbitts S, Konno R,
Settheetham-Ishida W, et al: Geographical distribution and
oncogenic risk association of human papillomavirus type 58 E6 and
E7 sequence variations. Int J Cancer. 132:2528–2536. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xi LF, Schiffman M, Koutsky LA, Hughes JP,
Hulbert A, Shen Z, Galloway DA and Kiviat NB: Variant-specific
persistence of infections with human papillomavirus Types 31, 33,
45, 56 and 58 and risk of cervical intraepithelial neoplasia. Int J
Cancer. 139:1098–1105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Insinga RP, Perez G, Wheeler CM, Koutsky
LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M,
Hernandez-Avila M, et al: Incident cervical HPV infections in young
women: Transition probabilities for CIN and infection clearance.
Cancer Epidemiol Biomarkers Prev. 20:287–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Trottier H, Mahmud S, Prado JC, Sobrinho
JS, Costa MC, Rohan TE, Villa LL and Franco EL: Type-specific
duration of human papillomavirus infection: Implications for human
papillomavirus screening and vaccination. J Infect Dis.
197:1436–1447. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raiol T, de Amorim RM, Galante P, Martins
CR, Villa LL and Sichero L: HPV-58 molecular variants exhibit
different transcriptional activity. Intervirology. 54:146–150.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van den Brule AJ, Meijer CJ, Bakels V,
Kenemans P and Walboomers JM: Rapid detection of human
papillomavirus in cervical scrapes by combined general
primer-mediated and type-specific polymerase chain reaction. J Clin
Microbiol. 28:2739–2743. 1990.PubMed/NCBI
|
